VivoSim Labs Inc. is a pharmaceutical and biotechnology services company focused on testing drugs and drug candidates in three-dimensional human tissue models of the liver and intestine. The company provides human-relevant toxicology insights through its new approach methodologies, including customizable NAMkind™ models designed to evaluate liver toxicity, intestinal toxicity, permeability, and related drug properties. VivoSim Labs also supports investigational toxicology, mechanism-of-action studies, predictive screening, and research services for pharmaceutical and biotechnology partners at different stages of drug development. Based in San Diego, California, VivoSim Labs plays a specialized role in preclinical testing by using complex human tissue systems to help researchers study drug behavior in a more biologically relevant environment.
Website11555 Sorrento Valley Road
San Diego, CA, 92121
United States
Investors talking about ONVO also mention
What share of all stock conversation is about ONVO?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% +0 | 0% new | 0.01% +0.01 | 0% 0 |
Of the messages about ONVO that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | — | — | 68.42% -31.58 | 98.3% +16.97 | ||
| Bearish | — | — | 31.58% +31.58 | 1.7% -16.97 |
Of the messages about ONVO that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Macro | 0% | — | 33.28% | 40.54% | ||
| Announcements | 0% | — | -0.05% | 8.16% | ||
| Analysts | 100% | — | 33.26% | 34.69% | ||
| Earnings | 0% | — | 33.51% | 16.62% | ||
| Controversies | 0% | — | 0% | 0% | ||
| Technical Analysis | 0% | — | 0% | 0% |
Of the messages about ONVO, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | 25% | -21.43% | 2.22% | 44.42% | ||
| Newcomers | 75% | 121.43% | 97.78% | 55.58% |